The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

Until recently, the molecular diagnosis of hereditary breast and ovarian cancer (HBOC) was mostly based on BRCA1/2 testing. Next generation sequencing and the recent discovery of new genes involved in HBOC now permit the transfer of genomic capture targeting multiple candidate genes from research to...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Eliade, Marie, Skrzypski, Jeremy, Baurand, Amandine, Jacquot, Caroline, Bertolone, Geoffrey, Loustalot, Catherine, Coutant, Charles, Guy, France, Fumoleau, Pierre, Duffourd, Yannis, Arnould, Laurent, Delignette, Alexandra, Padéano, Marie-Martine, Lepage, Côme, Raichon-Patru, Géraldine, Boudrant, Axelle, Bône-Lépinoy, Marie-Christine, Villing, Anne-Laure, Charpin, Aurélie, Peignaux, Karine, Chevrier, Sandy, Vegran, Frédérique, Ghiringhelli, François, Boidot, Romain, Sevenet, Nicolas, Lizard, Sarab, Faivre, Laurence
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Priority Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356770/
https://ncbi.nlm.nih.gov/pubmed/27779110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12699
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires